Anadrol vs CJC-1295 with DAC
FDA Approved vs Well Studied
synergistic Mechanism-based · 60% CJC-1295 with DAC helps manage estrogen conversion from Anadrol. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.
Molecular Data
Anadrol CJC-1295 with DAC
Weight 332.48 Da 3,647.28 Da
Half-life ~8-9 hours 6-8 days
Chain — 30 amino acids
Type 17-alpha alkylated anabolic steroid (C21H32O3) GHRH analog with DAC
Key Benefits
Anadrol
01 Rapid and dramatic increases in muscle mass and bodyweight
02 Exceptional strength gains, often noticeable within the first week
03 Potent stimulation of erythropoietin and red blood cell production
04 Increased appetite and nutrient partitioning in some users
05 Improved recovery between training sessions
06 Full, round muscle appearance due to intramuscular water and glycogen retention
07 FDA-approved treatment for various forms of anemia
CJC-1295 with DAC
01 Convenient weekly dosing
02 Sustained GH/IGF-1 elevation
03 6-8 day half-life
04 Significant body composition changes
Dosing Protocols
Anadrol
25-50 mg/day / Once or twice daily (oral)
CJC-1295 with DAC
1-2mg weekly / Once or twice weekly (e.g., Monday/Thursday for split dosing)
Conservative Anti-Aging 1mg Once weekly
Standard Protocol 2mg Once weekly
Split Dosing 1mg Twice weekly (Mon/Thu)
Loading Protocol 2mg first week, then 1mg Weekly
Side Effects
Anadrol
Significant water retention and bloating (estrogenic, not aromatase-mediated)
Elevated blood pressure (fluid volume and RBC increase)
Severe liver stress and elevated liver enzymes (AST/ALT)
Back pumps and lower back pain during exercise
Headaches (often blood pressure-related)
Appetite suppression (paradoxical for a mass-building compound)
Lethargy and fatigue (hepatic strain-related)
Acne and oily skin
Suppression of natural testosterone production
CJC-1295 with DAC
Water retention
Joint pain
Carpal tunnel symptoms
Contraindications
Pre-existing liver disease or significantly elevated liver enzymes
Prostate cancer or breast cancer in males
Nephrotic phase of nephritis
Hypercalcemia (Anadrol can exacerbate calcium levels)
Pregnancy (Category X - causes virilization of the female fetus)
Known hypersensitivity to oxymetholone
Concurrent use of other 17-alpha alkylated oral steroids (compounded liver toxicity)
Diabetes history
Cancer history
Predisposed sleep apnea
Research Evidence
Anadrol CJC-1295 with DAC
Status FDA Approved Well Studied
References 5 studies 4 studies
Latest 2018 2025
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.